Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung (LUX-Lung 8): an open-label randomised controlled phase 3 trial
| Image |  |
|---|---|
| Description | scientific article published on 05 July 2015 |
| Author/s |
author: Alessandro Morabito Andrea Ardizzoni Bushi Wang Enriqueta Felip Glenwood D Goss Jean-Charles Soria |
| Publication date | July 5, 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |